Explore

Trendline Trendline
Precision BioSciences to Announce Q1 2026 Financial Results Amid Gene Editing Advancements

Precision BioSciences to Announce Q1 2026 Financial Results Amid Gene Editing Advancements

Precision BioSciences to Announce Q1 2026 Financial Results Amid Gene Editing Advancements
Trendline Trendline
NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call

Lucid Diagnostics Announces Upcoming Business Update Conference Call

Lucid Diagnostics Announces Upcoming Business Update Conference Call
Trendline Trendline
Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call
Trendline Trendline
Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy
Trendline Trendline
Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights
Trendline Trendline
Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast
Trendline Trendline
NutriBand Reports $2.04 Million Revenue, Faces Significant Losses in Fiscal 2026

NutriBand Reports $2.04 Million Revenue, Faces Significant Losses in Fiscal 2026

NutriBand Reports $2.04 Million Revenue, Faces Significant Losses in Fiscal 2026
Trendline Trendline
Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion
Trendline Trendline
Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026
Trendline Trendline
Arcturus Therapeutics to Announce Q1 Financial Results and Corporate Update

Arcturus Therapeutics to Announce Q1 Financial Results and Corporate Update

Arcturus Therapeutics to Announce Q1 Financial Results and Corporate Update